How to buy Genpact stock | $41.36

Genpact Limited is an information technology services business based in the US. Genpact shares (G) are listed on the NYSE and all prices are listed in US Dollars. Genpact employs 96,300 staff and has a trailing 12-month revenue of around USD$3.7 billion.

How to buy shares in Genpact

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Genpact. Find the stock by name or ticker symbol: G. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Genpact reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$41.36, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Genpact, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Genpact. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Genpact share price

Use our graph to track the performance of G stocks over time.

Genpact shares at a glance

• Key figures

Information last updated 2020-12-27.

Latest market close	USD$41.36
52-week range	USD$19.2631 - USD$44.7452
50-day moving average	USD$40.8829
200-day moving average	USD$39.0014
Wall St. target price	USD$45.11
PE ratio	25.9317
Dividend yield	USD$0.39 (0.93%)
Earnings per share (TTM)	USD$1.61

Buy Genpact shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Genpact stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Genpact Limited by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genpact price performance over time

Historical closes compared with the close of $41.36 from 2020-12-31

1 week (2021-01-08)	-0.34%
1 month (2020-12-15)	0.51%
3 months (2020-10-15)	6.65%
6 months (2020-07-15)	13.91%

1 year (2020-01-15)	-6.21%
2 years (2019-01-15)	46.10%
3 years (2018-01-12)	24.88%
5 years (2016-01-15)	76.60%

Is Genpact under- or over-valued?

Valuing Genpact stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genpact's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Genpact's P/E ratio

Genpact's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Genpact shares trade at around 26x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

Genpact's PEG ratio

Genpact's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Genpact's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Genpact's EBITDA

Genpact's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$575.6 million.

The EBITDA is a measure of a Genpact's overall financial performance and is widely used to measure a its profitability.

Genpact financials

Revenue TTM	USD$3.7 billion
Operating margin TTM	11.74%
Gross profit TTM	USD$1.2 billion
Return on assets TTM	6.1%
Return on equity TTM	18.65%
Profit margin	8.53%
Book value	$9.334
Market capitalisation	USD$7.9 billion

TTM: trailing 12 months

Shorting Genpact shares

There are currently 3.2 million Genpact shares held short by investors – that's known as Genpact's "short interest". This figure is 26.2% up from 2.6 million last month.

There are a few different ways that this level of interest in shorting Genpact shares can be evaluated.

Genpact's "short interest ratio" (SIR)

Genpact's "short interest ratio" (SIR) is the quantity of Genpact shares currently shorted divided by the average quantity of Genpact shares traded daily (recently around 706178.07017544). Genpact's SIR currently stands at 4.56. In other words for every 100,000 Genpact shares traded daily on the market, roughly 4560 shares are currently held short.

However Genpact's short interest can also be evaluated against the total number of Genpact shares, or, against the total number of tradable Genpact shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genpact's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Genpact shares in existence, roughly 20 shares are currently held short) or 0.0194% of the tradable shares (for every 100,000 tradable Genpact shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genpact.

Find out more about how you can short Genpact stock.

Genpact share dividends

Dividend payout ratio: 17.89% of net profits

Recently Genpact has paid out, on average, around 17.89% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.93% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genpact shareholders could enjoy a 0.93% return on their shares, in the form of dividend payments. In Genpact's case, that would currently equate to about $0.39 per share.

While Genpact's payout ratio might seem low, this can signify that Genpact is investing more in its future growth.

Genpact's most recent dividend payout was on 23 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 8 December 2020 (the "ex-dividend date").

Genpact share price volatility

Over the last 12 months, Genpact's shares have ranged in value from as little as $19.2631 up to $44.7452. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genpact's is 1.3265. This would suggest that Genpact's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Genpact overview

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company's finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. It also provides transformation services; core industry operation services; and sourcing, procurement, and supply chain services, such as direct and indirect strategic sourcing, category management, spend analytics, procurement operations, master data management, and other procurement and supply chain advisory services. The company's IT services comprise end-user computing support, infrastructure management, application production support, and database management services, as well as business intelligence and data, enterprise resource planning, quality assurance, technology integration, and business intelligence reporting services. It serves banking, capital markets, insurance, consumer goods, retail, life sciences, healthcare, high tech, and manufacturing and services industries. Genpact Limited was founded in 1997 and is based in Hamilton, Bermuda.

Frequently asked questions

• What percentage of Genpact is owned by insiders or institutions?

  Currently 0.584% of Genpact shares are held by insiders and 104.458% by institutions.

• How many people work for Genpact?

  Latest data suggests 96,300 work at Genpact.

• When does the fiscal year end for Genpact?

  Genpact's fiscal year ends in December.

• Where is Genpact based?

  Genpact's address is: Victoria Place, Hamilton, Bermuda, HM 10

• What is Genpact's ISIN number?

  Genpact's international securities identification number is: BMG3922B1072

• What is Genpact's CUSIP number?

  Genpact's Committee on Uniform Securities Identification Procedures number is: G3922B107